Evaluation of Limiting Brain Penetration Related to P-glycoprotein and Breast Cancer Resistance Protein Using [11C]GF120918 by PET in Mice
- 9 April 2010
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 13 (1) , 152-160
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in ratsNuclear Medicine and Biology, 2009
- In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [11C]gefitinibNuclear Medicine and Biology, 2009
- P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of TopotecanClinical Cancer Research, 2007
- Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude miceJournal of Cancer Research and Clinical Oncology, 2007
- A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer PatientsClinical Cancer Research, 2007
- Measurement of Methylphenidate-Induced Change in Extrastriatal Dopamine Concentration using [11C]FLB 457 PETJournal of Cerebral Blood Flow & Metabolism, 2007
- Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)Oncogene, 2003
- Synthesis and Activity against Multidrug Resistance in Chinese Hamster Ovary Cells of New Acridone-4-carboxamidesJournal of Medicinal Chemistry, 1995
- Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptorsThe International Journal of Applied Radiation and Isotopes, 1985
- The Synthesis of Substituted 9-Oxoacridan-4-carboxylic Acids; Part 2. The Use of 2-lodoisophthalic Acid in the Jourdan-Ullmann ReactionSynthesis, 1985